Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
Poremba C, Hero B, Heine B, Scheel C, Schaefer KL, Christiansen H, Berthold F, Kneif S, Stein H, Juergens H, Boecker W, Dockhorn-Dworniczak B.
Poremba C, et al. Among authors: christiansen h.
Med Pediatr Oncol. 2000 Dec;35(6):651-5. doi: 10.1002/1096-911x(20001201)35:6<651::aid-mpo36>3.0.co;2-i.
Med Pediatr Oncol. 2000.
PMID: 11107139